News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
A new biomarker for a form of muscular dystrophy could improve disease monitoring in patients
Researchers from the Tapscott lab identified KHDC1L as a circulating biomarker for DUX4 activity in facioscapulohumeral muscular dystrophy. Facioscapulohumeral muscular dystrophy is driven by abnormal
Seattle’s life sciences market is “stable” despite a drop in federal funding last year
Seattle’s life sciences market remains stable despite declines in federal and venture funding, according to Colliers’ 2026 outlook report. The report highlights continued leasing activity
From computer to lab to market: Nobel winner David Baker lands $7M for new protein program
Nobel Laureate David Baker is leading a new University of Washington initiative backed by $7 million to develop designer enzymes and proteins for applications in
BARDA Contracts Just – Evotec to Optimize Biomanufacturing of Antibodies Against Filovirus
Just – Evotec Biologics has been awarded a multi-year contract by BARDA to optimize the biomanufacturing of monoclonal antibodies targeting filovirus diseases including Ebola and
Seattle’s biotech scene is world-class — Life Science Washington is teaching it how to brag
Life Science Washington is helping founders strengthen investor messaging while promoting Seattle’s position as a leading hub for AI-driven biotechnology. Marc Cummings highlighted the growing
Sana sees 14-month insulin production for transplanted islet therapy in single Type 1 diabetes patient
Sana Biotechnology reported that its donor-derived islet cell therapy continued producing insulin for 14 months in one patient with Type 1 diabetes, with no safety
Vertex races to FDA after phase 3 kidney disease data impress analysts
Vertex reported phase 3 data showing povetacicept significantly reduced proteinuria compared to placebo in immunoglobulin A nephropathy and said it plans to seek FDA approval
LSW Institute is Now LSW Entrepreneurship & Venture Services
To better serve a broader range of entrepreneurs and companies, LSW Institute is now LSW Entrepreneurship & Venture Services, offering a wider range of support
Seattle biotech inks licensing deal for opioid abuse treatments
Seattle-based CounterX Therapeutics has secured exclusive licensing agreements with the University of Washington and the University of Minnesota to develop treatments aimed at preventing opioid
University of Washington team working on CPR feedback device wins health innovation challenge
A team from the University of Washington won the 2026 Hollomon Health Innovation Challenge with CPRight, a device designed to provide real-time feedback that improves
Lawmakers must restore funding to train high-tech workforce
Washington has a problem. We have too many good jobs. Why is that a problem? Not enough of them are going to Washingtonians. As leaders
9 Biggest Biotech and Life Science Companies In Seattle
Seattle’s life sciences ecosystem stands out for companies applying artificial intelligence to accelerate drug discovery, diagnostics and therapeutic development. Greater Seattle ranks among the top